#Clinical Trials

Articles tagged "Clinical Trials"

Roche's CT-388 Achieves 22.5% Weight Loss in Phase 2 Trial
News

Roche's CT-388 Achieves 22.5% Weight Loss in Phase 2 Trial

Roche's investigational obesity drug CT-388 demonstrated 22.5% placebo-adjusted weight loss at 48 weeks in Phase 2 trial, advancing to Phase 3 studies.

New Ingestible Capsule Offers Drug-Free Solution for Weight Management
Research and Development

New Ingestible Capsule Offers Drug-Free Solution for Weight Management

FDA-cleared Epitomee capsule offers drug-free weight loss for BMI 25-40 adults. This ingestible device expands in the stomach to promote fullness without medications.